These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


134 related items for PubMed ID: 16375257

  • 1. Quality control system to support comparability assessment for the Renal Bio-Replacement therapy system.
    Pitkin Z.
    Dev Biol (Basel); 2005; 122():131-8. PubMed ID: 16375257
    [Abstract] [Full Text] [Related]

  • 2. Regulatory philosophy for comparability protocols.
    Moos M.
    Dev Biol (Basel); 2002; 109():53-6. PubMed ID: 12434913
    [Abstract] [Full Text] [Related]

  • 3. Current regulatory issues in cell and tissue therapy.
    Burger SR.
    Cytotherapy; 2003; 5(4):289-98. PubMed ID: 12944234
    [Abstract] [Full Text] [Related]

  • 4. International Conference on Harmonisation; guidance on Q5E Comparability of Biotechnological/Biological Products Subject to Changes in Their Manufacturing Process; availability. Notice.
    Food and Drug Administration, HHS.
    Fed Regist; 2005 Jun 30; 70(125):37861-2. PubMed ID: 15988855
    [Abstract] [Full Text] [Related]

  • 5. Microarray-based gene expression analysis as a process characterization tool to establish comparability of complex biological products: scale-up of a whole-cell immunotherapy product.
    Wang M, Senger RS, Paredes C, Banik GG, Lin A, Papoutsakis ET.
    Biotechnol Bioeng; 2009 Nov 01; 104(4):796-808. PubMed ID: 19591186
    [Abstract] [Full Text] [Related]

  • 6. [Education of laboratory technicians at graduate school contributes to development of advanced medical sciences and therapeutics].
    Maekawa T.
    Rinsho Byori; 2004 May 01; 52(5):430-4. PubMed ID: 15206130
    [Abstract] [Full Text] [Related]

  • 7. International Conference on Harmonisation; guidance on Q10 Pharmaceutical Quality System; availability. Notice.
    Food and Drug Administration, HHS.
    Fed Regist; 2009 Apr 08; 74(66):15990-1. PubMed ID: 19507321
    [Abstract] [Full Text] [Related]

  • 8. Will regulation be the death of cell therapy in the United States?
    Gastineau DA.
    Bone Marrow Transplant; 2004 Apr 08; 33(8):777-80. PubMed ID: 14968138
    [Abstract] [Full Text] [Related]

  • 9. Characterization of gene therapy products and the impact of manufacturing changes on product comparability.
    Simek SL.
    Dev Biol (Basel); 2005 Apr 08; 122():139-44. PubMed ID: 16375258
    [Abstract] [Full Text] [Related]

  • 10. The implementation of tissue banking experiences for setting up a cGMP cell manufacturing facility.
    Arjmand B, Emami-Razavi SH, Larijani B, Norouzi-Javidan A, Aghayan HR.
    Cell Tissue Bank; 2012 Dec 08; 13(4):587-96. PubMed ID: 21870140
    [Abstract] [Full Text] [Related]

  • 11. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H, Namba K.
    Kekkaku; 2006 Dec 08; 81(12):753-74. PubMed ID: 17240921
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Stem cell-based cell therapy in neurological diseases: a review.
    Kim SU, de Vellis J.
    J Neurosci Res; 2009 Aug 01; 87(10):2183-200. PubMed ID: 19301431
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The future of antihypertensive treatment.
    Israili ZH, Hernández-Hernández R, Valasco M.
    Am J Ther; 2007 Aug 01; 14(2):121-34. PubMed ID: 17414579
    [Abstract] [Full Text] [Related]

  • 17. The International Liaison Committee on Resuscitation (ILCOR) consensus on science with treatment recommendations for pediatric and neonatal patients: pediatric basic and advanced life support.
    International Liaison Committee on Resuscitation.
    Pediatrics; 2006 May 01; 117(5):e955-77. PubMed ID: 16618790
    [Abstract] [Full Text] [Related]

  • 18. Role of the blood service in cellular therapy.
    Rebulla P, Giordano R.
    Biologicals; 2012 May 01; 40(3):218-21. PubMed ID: 22063066
    [Abstract] [Full Text] [Related]

  • 19. When should renal replacement therapy for acute kidney injury be initiated and discontinued?
    Gibney RT, Bagshaw SM, Kutsogiannis DJ, Johnston C.
    Blood Purif; 2008 May 01; 26(5):473-84. PubMed ID: 18810230
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.